
NRC Health (NRC) Stock Forecast & Price Target
NRC Health (NRC) Analyst Ratings
Bulls say
NRC Health is supported by a differentiated healthcare-specific experience management platform, a 45-year operating history, and proprietary data that serves more than 250 of the country’s 400 largest health systems, giving it durable relevance in consumerism, transparency, and value-based care. Its 3Q26 results reinforced that setup, with revenue of $38.4M beating estimates by 7%, EBITDA of $10.9M above plan, and TRCV rising to $154M, while the large customer go-live and multi-year renewals point to stronger forward visibility. Management’s renewed focus on growth and retention, along with sequential margin improvement expected in 4Q and a path toward higher profitability, underpins a constructive view despite debt of $103M and shareholder capital returns.
Bears say
NRC Health is facing a weak fundamental setup because industry consolidation may prolong sales cycles, while efforts to reaccelerate Insights and TGI growth may fall short and make its expense assumptions too optimistic. Profitability also looks pressured, with SG&A at about 40% of revenue in 2025, or 31% excluding one-time and non-cash items, while recent growth appears concentrated in the top 10 customers, masking revenue compression from the rest of the base. The balance sheet and trading profile add risk, as management may fund dividends and buybacks with more capital than it generates, leverage could rise, and the 12M-share float with under 125K to 150K average daily volume suggests thin liquidity.
This aggregate rating is based on analysts' research of NRC Health and is not a guaranteed prediction by Public.com or investment advice.
NRC Health (NRC) Analyst Forecast & Price Prediction
Start investing in NRC Health (NRC)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About NRC Health (NRC) Forecast
NRC Health (NRC) Analyst Forecast & Price Prediction
Start investing in NRC Health (NRC)
Order type
Buy in
Order amount
Est. shares
0 shares